Management of retinoblastoma: opportunities and challenges

Drug Delivery
Dhiraj BhavsarUma Maheswari Krishnan

Abstract

Nano-delivery systems have significantly evolved over the last decade for the treatment of cancer by enabling site-specific delivery and improved bioavailability. The widely investigated nanoparticle systems are biodegradable polyesters, dendrimers, liposomes, mesoporous silica and gold nanoparticles. These particles when conjugated with different targeting motifs enhance the therapeutic efficiency of the drug molecules and biocompatibility. However, the application of such systems towards the treatment of retinoblastoma (RB), a rapidly spreading childhood eye cancer, still remains in its infancy. Nanoparticle-based systems that have been investigated for RB therapy have displayed improved drug delivery to the most restricted posterior segment of the eyes and have increased intra-vitreal half-life of the chemotherapy agents highlighting its potential in treatment of this form of cancer. This review focuses on the challenges involved in the treatment of RB and highlights the attempts made to develop nano-dimensional systems for the treatment of RB.

References

Mar 1, 1990·International Ophthalmology·E V SmithD J D'Amico
Jun 15, 1989·Nature·T P DryjaD W Yandell
Nov 1, 1988·Ophthalmology·J D RoartyL E Zimmerman
Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Jun 1, 1981·The Journal of General Physiology·B S Winkler
Apr 1, 1996·International Journal of Radiation Oncology, Biology, Physics·J C HernandezA Singh
Feb 1, 1997·Ophthalmology·Z A KarciogluP B Mullaney
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L FriedmanA T Meadows
Jun 6, 2000·Advanced Drug Delivery Reviews·M S Shive, J M Anderson
Jul 16, 2003·Archives of Ophthalmology·Daniel A SussmanTimothy G Murray
Jul 29, 2003·Investigative Ophthalmology & Visual Science·Jean-Louis BourgesFrancine F Behar-Cohen
Oct 1, 2003·American Journal of Ophthalmology·Thomas S ShaneUNKNOWN Endopthalmitis-Gancioclovir Implant Study Group
Apr 27, 2004·International Journal of Clinical Oncology·Takashi YamaneMakoto Mohri
Jul 20, 2004·The British Journal of Ophthalmology·C Leal-LealF Carrete-Ramírez
Jun 14, 2005·Psychoneuroendocrinology·Irina A Antonijevic
Jul 16, 2005·Cancer Chemotherapy and Pharmacology·Wanida ChearwaePornngarm Limtrakul
Jul 27, 2005·Investigative Ophthalmology & Visual Science·David H Abramson
Nov 16, 2005·Archives of Ophthalmology·Hakan DemirciJerry A Shields
Aug 1, 2006·American Journal of Ophthalmology·Ingo SchmackHans E Grossniklaus
Aug 8, 2006·Journal of Biochemistry and Molecular Biology·Jung Hun KimKyu-Won Kim
Aug 29, 2006·Oncogene·A BalmerF Munier
Sep 26, 2006·Ophthalmology·Carol L ShieldsJerry A Shields
Oct 27, 2007·The Oncologist·Murali ChintagumpalaRichard Hurwitz
Nov 10, 2007·Current Oncology Reports·Dan S Gombos, And Patricia Chevez-Barrios
Jun 10, 2008·Cancer Treatment Reviews·Lara S Jabr-MilaneMansoor M Amiji
Aug 9, 2008·International Journal of Nanomedicine·Wim H De Jong, Paul J A Borm
Sep 3, 2008·Pediatrics·Carlos Rodriguez-GalindoJudith Wilimas
Dec 3, 2008·Pediatrics·UNKNOWN American Academy of PediatricsUNKNOWN American Association of Certified Orthoptists
Feb 6, 2009·Pharmaceutical Research·Esther S KimHenry F Edelhauser
Aug 12, 2009·Archives of Ophthalmology·Shin J KangHans E Grossniklaus
Jan 8, 2010·Investigative Ophthalmology & Visual Science·Yuta InokuchiHideaki Hara
Mar 13, 2010·Current Opinion in Ophthalmology·Carol L Shields, Jerry A Shields
Jun 30, 2010·Clinical & Experimental Ophthalmology·Carol L Shields, Jerry A Shields
Jul 14, 2010·Journal of Biomedical Science·Lakshmi N RamanaUma M Krishnan
Dec 1, 2008·Journal of Biomedical Nanotechnology·Ashwin NairLiping Tang
Sep 30, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Sai H S BodduAshim K Mitra
Dec 9, 2010·International Ophthalmology Clinics·Samuel K HoustonCristina E Fernandes

❮ Previous
Next ❯

Citations

Jul 13, 2019·Journal of Biophotonics·Cécile DarviotMichel Meunier
May 25, 2016·Cancer Control : Journal of the Moffitt Cancer Center·Pia R Mendoza, Hans E Grossniklaus
May 17, 2018·Medicinal Research Reviews·Florence MasseElodie Boisselier
Sep 16, 2019·International Journal of Biological Macromolecules·Jia LiChenchen Zhang
Sep 9, 2019·Journal of Basic and Clinical Physiology and Pharmacology·Santosh Kumar PatnaikThirumurthy Velpandian
May 1, 2021·Journal of Clinical Medicine·Shicheng YangSrinivas Sridhar
Jul 3, 2021·NeoReviews·Monica ManriqueJana Bregman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Medical Devices
Rekha M Ramesan, Chandra P Sharma
International Journal of Nanomedicine
Guillermo U Ruiz-EsparzaRita E Serda
Macromolecular Bioscience
Shengyan LiuFrank X Gu
© 2022 Meta ULC. All rights reserved